Covid-19 has bought many biotech companies into the limelight, all promising a possible solution to the pandemic that has disrupted lives worldwide. In February 2021, Ocugen, Inc. (NASDAQ: OCGN) shares catapulted after news of the Company signing a binding letter of intent (LOI) with Bharat...
Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage company, announced that it has reached a consensus with the U.S. Food and Drug Administration (FDA), as to key elements of a crucial Phase 3 clinical program for Simufilam, its lead candidate for the treatment of Alzheimer’s. The...
T2 Biosystems, Inc. recently announced that its T2SARS-CoV-2™ Panel, a molecular diagnostic test that detects SARS-CoV-2, can detect the Brazil (P.1) variant of the SARS-CoV-2 virus. This expands the utility of its panel to reliably detect newer variants that have emerged in United Kingdom (B.1.1.7)...
TherapeuticsMD (NASDAQ: TXMD), is a women’s healthcare Company focused on creating novel solutions for challenges encountered by women in areas such as family planning, reproductive health, and menopause management. The Company’s product offerings include Annovera, a progestin/estrogen CHC vaginal birth control ring intended for contraception,...
Albireo Pharma, Inc. (NASDAQ: ALBO) a clinical-stage company targeting rare liver diseases, announced the acceptance of its New Drug Application (NDA) for odevixibat, a once-daily, non-systemic IBAT, intended for the treatment of pruritus in patients with progressive familial intrahepatic cholestasis (PFIC). The candidate is also...
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) are rallying after a discussion in r/wallstreetbets called it the “most undervalued stock in the market.” In January 2021, the Company had reported the grant of a marketing and manufacturing approval for oral, once-daily ORLADEYO™ (berotralstat) 150 mg for...
While Industries across the globe are grappling with the pandemic and its impact on their operations, Biotech Industry has been focused on minimizing the impact and marching ahead with its innovations and breakthroughs. We take a look at some Biotech’s that are impervious to the scare...
Galera Therapeutics (NASDAQ: GRTX), a clinical–stage Biopharmaceutical Company aiming to redefine radiotherapy in cancer, announced positive interim results from a phase 1/2 trial of GC4419 or avasopasem manganese. An investigational, highly selective small molecule superoxide dismutase mimetic, GC4419 has the potential to convert superoxide to...
GenMark Diagnostics (NASDAQ: GNMK), a Company developing molecular diagnostic tests based on its proprietary eSensor electrochemical detection technology, announced that the FDA has given the Company’s ePlex SARS-CoV-2 Test an emergency use authorization. The technology addresses a very important need for quick and easy detection...
Agenus Inc (NASDAQ: AGEN), a clinical-stage immune-oncology company developing innovative therapies for treatment of cancer, announced the grant of a Fast Track designation for investigation of balstilimab [PD-1] in combination with zalifrelimab [CTLA-4] for the treatment of patients with relapsed or refractory metastatic cervical cancer. [caption...
